Cargando…
Brain differential gene expression and blood cross-validation of a molecular signature of patients with major depressive disorder
INTRODUCTION: The agreement between clinicians diagnosing major depressive disorder (MDD) is poor. The objective of this study was to identify a reproducible and robust gene expression marker capable of differentiating MDD from healthy control (HC) subjects. MATERIALS AND METHODS: Brain and blood ge...
Autores principales: | Gomez Rueda, Hugo, Bustillo, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071037/ https://www.ncbi.nlm.nih.gov/pubmed/35030558 http://dx.doi.org/10.1097/YPG.0000000000000309 |
Ejemplares similares
-
Molecular Signatures of Major Depression
por: Cai, Na, et al.
Publicado: (2015) -
Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression
por: Hu, Guoqin, et al.
Publicado: (2021) -
Convergent molecular, cellular, and cortical neuroimaging signatures of major depressive disorder
por: Anderson, Kevin M., et al.
Publicado: (2020) -
The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023) -
Identification of diagnostic markers for major depressive disorder by cross-validation of data from whole blood samples
por: Wang, Huimei, et al.
Publicado: (2019)